免疫功能正常宿主中的播散性球孢子菌病:提高识别与及时诊断的机会
该研究回顾了7年内40例免疫功能正常宿主播散性球孢子菌病病例,发现100%病例通过FDA批准的酶免疫试验检测到IgG抗体阳性,87%诊断延迟且71%病情恶化。结论强调需提高对危险因素、症状和适当检测选项的认识。
要点
- 免疫功能正常宿主也可发生播散性球孢子菌病,诊断常延迟。
- FDA批准的球孢子菌酶免疫试验IgG抗体在全部40例中阳性。
- 诊断延迟与病情恶化相关,需加强基层和急诊识别。
核心结论
- 免疫功能正常宿主的播散性球孢子菌病诊断延迟常见,FDA批准的酶免疫试验IgG抗体检测可能有助于筛查。
研究设计与样本
- 回顾性分析7年内40例免疫功能正常宿主的播散性球孢子菌病病例,来自单一机构。
主要发现
- 100%病例(40/40)FDA批准的球孢子菌酶免疫试验IgG抗体阳性。
- 87%病例诊断延迟,71%病例病情恶化。
- 初始就诊导致延迟识别的场所: primary care 56%、急诊33%、 urgent care 11%。
关键数值与推荐
- 40例均通过FDA批准的球孢子菌酶免疫试验检测到IgG抗体阳性。
临床怎么用
- 在流行区,对免疫功能正常但疑似播散性球孢子菌病患者,应考虑使用FDA批准的酶免疫试验检测IgG抗体以辅助诊断。
局限性
- 单中心回顾性研究,样本量40例,结果可能受选择偏倚影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While most pulmonary infections with Coccidioides spp. are self-limited, a subset of patients is at higher risk for severe disease and extrapulmonary dissemination, including individuals with certain ethnic backgrounds. Disseminated disease can involve soft tissues, bones, and the central nervous system with high morbidity and mortality in the absence of antifungal treatment. Diagnosis of coccidioidomycosis can be challenged by the availability of specimens for culture or histopathology, confusion with, or lack of availability of various antibody tests and overall lack of consideration of Coccidioides spp. as the etiology of disease, especially in immunocompetent hosts. METHODS: We set out to characterize cases of disseminated coccidioidomycosis at our institution over a 7-year period, solely in immunocompetent hosts, to highlight diagnostic delays and determine which, if any, primary screening test might be the most useful. RESULTS: A total of 40 cases met our inclusion criteria, and 100% of these cases had positive immunoglobulin G antibodies on a US FDA-cleared Coccidioides spp. enzyme immunoassay. Nearly all of the cases (87%) had a delay in diagnosis and associated worsening of disease (71%). Locations of initial presentations that led to delayed recognition included primary care settings (56%), emergency departments (33%), and urgent care centers (11%), all in the region of Coccidioides spp. endemicity. CONCLUSIONS: These findings highlight the need for interventions to increase awareness of the risk factors for, the symptoms of, and the appropriate testing options to diagnose disseminated coccidioidomycosis.
引用
- Hoge ACH, Grys TE, Graf EH, et al. Disseminated Coccidioidomycosis in Immunocompetent Hosts: Opportunities for Increased Recognition and Timely Diagnosis. Clin Chem. 2026. PMID: 41603603. doi:10.1093/clinchem/hvaf187
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。